Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.

Journal article

Nazarzadeh M. et al, (2021), Lancet, 398, 1803 - 1810

Blood pressure treatment: how low should you go? - Authors' reply.

Journal article

Rahimi K. et al, (2021), Lancet, 398, 1684 - 1685

Reply: How low should you go?

Journal article

CANOY D. et al, (2021), The Lancet

Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

Journal article

Copland E. et al, (2021), The Lancet Oncology, 22, 558 - 570

BLOOD PRESSURE-LOWERING, ANTIHYPERTENSIVE TREATMENT AND INCIDENT DIABETES

Conference paper

Nazarzadeh M. et al, (2021), JOURNAL OF HYPERTENSION, 39, E8 - E9

YY EFFECTS OF BLOOD PRESSURE-LOWERING ON CANCER RISK: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 300,000 PARTICIPANTS

Conference paper

Copland E. et al, (2021), JOURNAL OF HYPERTENSION, 39, E7 - E7

Effect of blood pressure lowering treatment on the risk of atrial fibrillation: an individual-participant data meta-analysis

Conference paper

Pinho-Gomes AC. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2771 - 2771

Load More